ReviewEClinicalMedicine2025

Use of surrogate endpoints in health technology assessment and reimbursement of treatments for the management of chronic kidney disease.

Rod S Taylor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.